ArticleCurrent eye research2020
Therapeutic Effects of Lyophilized Conditioned-Medium Derived from Corneal Mesenchymal Stromal Cells on Corneal Epithelial Wound Healing.
Open access · greenAbstract read
In one paragraph
Article in Current eye research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 31 citations in OpenAlex.
- Novel sponge formulation of mesenchymal stem cell secretome and hyaluronic acid: a safe and effective topical therapy for Psoriasis vulgaris.Stem cell research & therapy · 2025Trial
- Corneal Nerve Regeneration via MSC-Derived EVs: Tissue Source and Culture Dimensionality Dictate miRNA Cargo and Therapeutic Efficacy.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Comparative analysis of human Mesenchymal Stromal Cells from Adipose Tissue and Dental Pulp: phenotypic characterization and secretome profiling.Biology direct · 2025Article
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies.Signal transduction and targeted therapy · 2025Review
- Method standardization of secretome production, collection, and characterization: New insights and challenges.Regenerative therapy · 2025Review
- Human cornea-derived mesenchymal stromal cells inhibit T cells through indoleamine 2,3 dioxygenase.Cytotherapy · 2025Article
- The impact of the limbal niche interactions on the self-renewal capability of limbal epithelial stem cells.Frontiers in cell and developmental biology · 2025Article
- Senescence and Stress Signaling Pathways in Corneal Cells After Nitrogen Mustard Injury.Cells · 2024Article
- Mitochondria Transplantation Promotes Corneal Epithelial Wound Healing.Investigative ophthalmology & visual science · 2024Article
- Storage conditions affect the composition of the lyophilized secretome of multipotent mesenchymal stromal cells.Scientific reports · 2024Article
- Article
- Wound-Healing Effects of Mesenchymal Stromal Cell Secretome in the Cornea and the Role of Exosomes.Pharmaceutics · 2023Article
- Effect of stem cell conditional medium-loading adhesive hydrogel on TGF-β1-induced endometrial stromal cell fibrosis.Frontiers in bioengineering and biotechnology · 2023Article
- Stability and Function of Extracellular Vesicles Derived from Immortalized Human Corneal Stromal Stem Cells: A Proof of Concept Study.The AAPS journal · 2022Article
- Therapeutic Potential of Mesenchymal Stem Cell-Secreted Factors on Delay in Corneal Wound Healing by Nitrogen Mustard.International journal of molecular sciences · 2022Article
- The Effect of Human Umbilical Cord-Derived Lyophilized Stem Cells on Fat Graft Viability: An Experimental Study.Aesthetic plastic surgery · 2022Article
- Potential Anti-Inflammatory Effects of a New Lyophilized Formulation of the Conditioned Medium Derived from Periodontal Ligament Stem Cells.Biomedicines · 2022Article
- Supramolecular host-guest hyaluronic acid hydrogels enhance corneal wound healing through dynamic spatiotemporal effects.The ocular surface · 2022Article
- Mesenchymal stromal cells for the treatment of ocular autoimmune diseases.Progress in retinal and eye research · 2021Review
- CM from intact hAM: an easily obtained product with relevant implications for translation in regenerative medicine.Stem cell research & therapy · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Sayena JabbehdariDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, Illinois, USA.ORCID 0000-0001-8850-4956
Ghasem YazdanpanahDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, Illinois, USA.ORCID 0000-0002-7518-8701
Levi N KanuDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, Illinois, USA.ORCID 0000-0001-6428-4696
Eric ChenDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, Illinois, USA.
Kai KangDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, Illinois, USA.
Khandaker N AnwarDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, Illinois, USA.
Mahmood GhassemiDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, Illinois, USA.
Peiman HemattiDepartment of Medicine and University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, School of Medicine and Public Health , Madison, Wisconsin, USA.
Mark I RosenblattDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, Illinois, USA.ORCID 0000-0001-8978-1955
Ali R DjalilianDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago , Chicago, Illinois, USA.ORCID 0000-0002-1489-0724
University of Illinois Chicago · USUniversity of Wisconsin–Madison · US
Funding
Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHUKLA, DEEPAK · 1985 to 2025
$14.8MUIC K12 Independent Clinical Vision Scientist Development ProgramK12EY021475 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ALI R DJALILIAN, CHARLOTTE E JOSLIN · 2011 to 2026
$6.7MNovel Therapies for Ocular Chemical InjuriesR01EY024349 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DJALILIAN, ALI R · 2015 to 2020
$2.1MNEI NIH HHS K12 EY021475NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY024349
Abstract
PubMed holds no abstract for this paper.
Indexed as
Culture Media, ConditionedStem Cell TransplantationAnimalsCorneal InjuriesEpithelium, CornealFreeze DryingHumansIntercellular Adhesion Molecule-1Interleukin-6Interleukin-8Limbus CorneaeMesenchymal Stem CellsMiceMice, Inbred BALB CToll-Like Receptor 3Tumor Necrosis Factor-alphaCulture Media, ConditionedIntercellular Adhesion Molecule-1Interleukin-6interleukin-6, mouseInterleukin-8TLR3 protein, mouseToll-Like Receptor 3Tumor Necrosis Factor-alphaconditioned mediaconditioned-mediumHuman cornealyophilizationmesenchymal stromal cellwound healing
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.